This paper reports on the development and validation of a new, global, burnt area product. Burnt areas are reported at a resolution of 1 km for seven fire years (2000 to 2007). A modified version of a Global Burnt Area (GBA) 2000 algorithm is used to compute global burnt area. The total area burnt each year (2000–2007) is estimated to be between 3.5 million km2 and 4.5 million km2. The total amount of vegetation burnt by cover type according to the Global Land Cover (GLC) 2000 product is reported. Validation was undertaken using 72 Landsat TM scenes was undertaken. Correlation statistics between estimated burnt areas are reported for major vegetation types. The accuracy of this new global data set depends on vegetation type.

Land cover is one of the essential climate variables of the ESA Climate Change Initiative (CCI). In this context, the Land Cover CCI (LC CCI) project aims at building global land cover maps suitable for climate modeling based on Earth observation by satellite sensors. The challenge is to generate a set of successive maps that are both accurate and consistent over time. To do so, operational methods for the automated classification of optical images are investigated. The proposed approach consists of a locally trained classification using an automated selection of training samples from existing, but outdated land cover information. Combinations of local extraction (based on spatial criteria) and self-cleaning of training samples (based on spectral criteria) are quantitatively assessed. Two large study areas, one in Eurasia and the other in South America, are considered. The proposed morphological cleaning of the training samples leads to higher accuracies than the statistical outlier removal in the spectral domain. An optimal neighborhood has been identified for the local sample extraction. The results are coherent for the two test areas, showing an improvement of the overall accuracy compared with the original reference datasets and a significant reduction of macroscopic errors. More importantly, the proposed method partly controls the reliability of existing land cover maps as sources of training samples for supervised classification.Remote Sens. 2014, 6 3966

No abstract

Bladder cancer (BC) is the 10th most common cancer globally and has a high mortality rate if not detected early and treated promptly. Non-muscle-invasive BC (NMIBC) is a subclassification of BC associated with high rates of recurrence and progression. Current tools for predicting recurrence and progression on NMIBC use scoring systems based on clinical and histopathological markers. These exclude other potentially useful biomarkers which could provide a more accurate personalized risk assessment. Future trends are likely to use artificial intelligence (AI) to enhance the prediction of recurrence in patients with NMIBC and decrease the use of standard clinical protocols such as cystoscopy and cytology. Here, we provide a comprehensive survey of the most recent studies from the last decade (N = 70 studies), focused on the prediction of patient outcomes in NMIBC, particularly recurrence, using biomarkers such as radiomics, histopathology, clinical, and genomics. The value of individual and combined biomarkers is discussed in detail with the goal of identifying future trends that will lead to the personalized management of NMIBC.

Based on CT measurements, the aorta-sacral promontory distance is decreased in elderly and hypertensive patients. Heavier patients have an increased aorta-sacral promontory distance. These potential anatomical variants should be considered before operating in the presacral space.

Hepatocellular carcinoma (HCC) is the most common primary hepatic neoplasm. Thanks to recent advances in computed tomography (CT) and magnetic resonance imaging (MRI), there is potential to improve detection, segmentation, discrimination from HCC mimics, and monitoring of therapeutic response. Radiomics, artificial intelligence (AI), and derived tools have already been applied in other areas of diagnostic imaging with promising results. In this review, we briefly discuss the current clinical applications of radiomics and AI in the detection, segmentation, and management of HCC. Moreover, we investigate their potential to reach a more accurate diagnosis of HCC and to guide proper treatment planning.

Globally, renal cancer (RC) is the 10th most common cancer among men and women. The new era of artificial intelligence (AI) and radiomics have allowed the development of AI-based computer-aided diagnostic/prediction (AI-based CAD/CAP) systems, which have shown promise for the diagnosis of RC (i.e., subtyping, grading, and staging) and prediction of clinical outcomes at an early stage. This will absolutely help reduce diagnosis time, enhance diagnostic abilities, reduce invasiveness, and provide guidance for appropriate management procedures to avoid the burden of unresponsive treatment plans. This survey mainly has three primary aims. The first aim is to highlight the most recent technical diagnostic studies developed in the last decade, with their findings and limitations, that have taken the advantages of AI and radiomic markers derived from either computed tomography (CT) or magnetic resonance (MR) images to develop AI-based CAD systems for accurate diagnosis of renal tumors at an early stage. The second aim is to highlight the few studies that have utilized AI and radiomic markers, with their findings and limitations, to predict patients’ clinical outcome/treatment response, including possible recurrence after treatment, overall survival, and progression-free survival in patients with renal tumors. The promising findings of the aforementioned studies motivated us to highlight the optimal AI-based radiomic makers that are correlated with the diagnosis of renal tumors and prediction/assessment of patients’ clinical outcomes. Finally, we conclude with a discussion and possible future avenues for improving diagnostic and treatment prediction performance.

No abstract